Financials

News Discussions Technicals Forecast Seasonals

ALTME fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

TME Pharma NV is a clinical-stage biopharmaceutical company, which focuses on therapeutics targeting the tumor microenvironment or TME. The firm is active in pioneering the development of a new class of proprietary therapeutics called Spiegelmers. Its pipeline includes NOX-A12 and NOX-E36. The company was founded on January 16, 2015 and is headquartered in Berlin, Germany.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

ALTME has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company